Use of conditional reprogramming cell, patient derived xenograft and organoid for drug screening for individualized prostate cancer therapy: Current and future perspectives (Review)-Reference-Cited by-同舟云学术

Use of conditional reprogramming cell, patient derived xenograft and organoid for drug screening for individualized prostate cancer therapy: Current and future perspectives (Review)

Published:2022-03-24 Issue:5 Volume:60 Page:
ISSN:1019-6439
Container-title:International Journal of Oncology
language:
Short-container-title:Int J Oncol

Author:

Cao Jessica¹,Chan Wing²,Chow Moses³

Affiliation:

1. College of Osteopathic Medicine of The Pacific, Western University of Health Sciences, Pomona, CA 91766‑1854, USA

2. City of Hope Comprehensive Cancer Center, City of Hope Medical Center, Duarte, CA 91010‑3012, USA

3. College of Pharmacy, Western University of Health Sciences, Pomona, CA 91766‑1854, USA

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference144 articles.

1. Cancer statistics, 2020;Siegel;CA Cancer J Clin,2020

2. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: The prostate cancer outcomes study;Stanford;JAMA,2000

3. Prostate cancer, version 2.2019, NCCN clinical practice guidelines in oncology;Mohler;J Natl Compr Canc Netw,2019

4. Update on systemic prostate cancer therapies: Management of metastatic castration-resistant prostate cancer in the era of precision oncology;Nuhn;Eur Urol,2019

5. Bone-targeted therapies to reduce skeletal morbidity in prostate cancer;Dorff;Asian J Androl,2018

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient-Derived Conditionally Reprogrammed Cells in Prostate Cancer Research;Cells;2024-06-08

2. Comparison of Surgical and Colonoscopy Tissue to Establish Colorectal Patient-derived Organoids;Current Cancer Drug Targets;2023-11-22

3. A quick and reliable image-based AI algorithm for evaluating cellular senescence of gastric organoids;Cancer Biology & Medicine;2023-06-30

4. Natural products as drug candidates for breast cancer (Review);Oncology Letters;2023-06-28

5. Patient-derived organoids in translational oncology and drug screening;Cancer Letters;2023-05